Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000667463 | SCV000791915 | uncertain significance | Alstrom syndrome | 2017-06-01 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000667463 | SCV003296283 | uncertain significance | Alstrom syndrome | 2022-01-04 | criteria provided, single submitter | clinical testing | This variant is not present in population databases (gnomAD no frequency). This sequence change replaces tyrosine, which is neutral and polar, with cysteine, which is neutral and slightly polar, at codon 1942 of the ALMS1 protein (p.Tyr1942Cys). This variant has not been reported in the literature in individuals affected with ALMS1-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. ClinVar contains an entry for this variant (Variation ID: 552237). |
Natera, |
RCV000667463 | SCV001465791 | uncertain significance | Alstrom syndrome | 2020-08-14 | no assertion criteria provided | clinical testing |